A 2-part Phase 1/2 Open-label Trial on ODM-212

Clinical trial NCT07563738 · RECRUITING

Trial details

NCT number: NCT07563738
Sponsor: Orion Corporation, Orion Pharma
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mesothelioma Pancreatic Cancer NSCLC (Advanced Non-small Cell Lung Cancer)

Start date: 2026-03-27
Primary completion: 2029-09-01
Enrollment: 229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.